KRChoksey has come out with its earning estimates on pharma sector for the quarter ended March 2011. According to the research firm, Glenmark Pharma March quarter sales are expected to go up by 10% at Rs 781 crore, year-on-year, (YoY) basis.
The company's net profit is expected to go down by 5% at Rs 98 crore on YoY basis.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
